Product Information
BISOPROLOL FUMARATE 5 MG TAB is a generic product labeled by Advagen Pharma Ltd., priced at $0.1142 per EA under NDC 72888009201. Its NADAC has been published 187 times since Mar 8, 2023.
FDA first approved this application on Nov 16, 2000. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Advagen Pharma Ltd.NDC
72888009201
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
BISOPROLOL FUMARATEApproval Type
Generic (ANDA)
FDA Application
ANDA075643FDA Approved
11/16/2000
TE Code
AB
On Market Since
11/16/2000
Pharmacological Classes
Price Statistics
The NADAC for BISOPROLOL FUMARATE 5 MG TAB has been published 187 times since Mar 8, 2023, and over the history we have for it it has declined 64.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1142 per EA |
|---|---|
| All-time high | $0.3258 (Mar 15, 2023) |
| All-time low | $0.1142 (Sep 23, 2026) |
| 52-week high | $0.1885 |
| 52-week low | $0.1142 |
| Median price | $0.1939 |
| Average price | $0.2171 |
| Largest weekly change | -32.3% (Nov 20, 2024) |
| Weeks tracked | 187 |
| Tracking since | Mar 8, 2023 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Advagen Pharma Ltd. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Bisoprolol Fumarate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
beta-Adrenergic Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BISOPROLOL FUMARATE 5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for BISOPROLOL FUMARATE 5 MG TAB, manufactured by Advagen Pharma Ltd., is $0.1142 per EA (NDC 72888009201), effective Sep 30, 2026.
How has the price of BISOPROLOL FUMARATE 5 MG TAB changed over time?
Over the history we have for it, the NADAC for BISOPROLOL FUMARATE 5 MG TAB has declined 64.9%. It has been tracked across 187 weekly CMS publications since Mar 8, 2023.
What are the highest and lowest recorded NADAC prices for BISOPROLOL FUMARATE 5 MG TAB?
Since Mar 8, 2023, the NADAC for BISOPROLOL FUMARATE 5 MG TAB has ranged from a low of $0.1142 (Sep 23, 2026) to a high of $0.3258 (Mar 15, 2023), with a median of $0.1939 per EA.
Are there cheaper alternatives to BISOPROLOL FUMARATE 5 MG TAB?
7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BISOPROLOL FUMARATE 5 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures BISOPROLOL FUMARATE 5 MG TAB?
BISOPROLOL FUMARATE 5 MG TAB (NDC 72888009201) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.